Ezetimibe therapy: mechanism of action and clinical update

Ezetimibe therapy: mechanism of action and clinical update

Item
http://www.wikidata.org/entity/Q24630302
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implicationsAddition of Ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient-important outcomes.The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes.A pilot study of ezetimibe vs. atorvastatin for improving peripheral microvascular endothelial function in stable patients with type 2 diabetes mellitus.Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment.Monitoring of lipids, enzymes, and creatine kinase in patients on lipid-lowering drug therapyRESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of JapA case of abdominal pain with dyslipidemia: difficulties diagnosing cholesterol ester storage disease.Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver diseaseEzetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigs.Ezetimibe: an update on its clinical usefulness in specific patient groups.High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes.Cardiovascular risk and dyslipidemia among persons living with HIV: a review.Using inactivating mutations to provide insight into drug actionDifferential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles.Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.Large-scale computational drug repositioning to find treatments for rare diseases.
P2860

Ezetimibe therapy: mechanism of action and clinical update

Item
http://www.wikidata.org/entity/Q24630302
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Ezetimibe therapy: mechanism of action and clinical update
@ast
Ezetimibe therapy: mechanism of action and clinical update
@en
Ezetimibe therapy: mechanism of action and clinical update
@nl
type
label
Ezetimibe therapy: mechanism of action and clinical update
@ast
Ezetimibe therapy: mechanism of action and clinical update
@en
Ezetimibe therapy: mechanism of action and clinical update
@nl
prefLabel
Ezetimibe therapy: mechanism of action and clinical update
@ast
Ezetimibe therapy: mechanism of action and clinical update
@en
Ezetimibe therapy: mechanism of action and clinical update
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932
P356
P1433
P1476
Ezetimibe therapy: mechanism of action and clinical update
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932